Methods and compositions relating to nucleic acids targeting certain miRNAmolecules are disclosed. The nucleic acids are useful, for example, in methodsof increasing the expression and/or secretion of EPO and treating various diseasestates including anemia, hemophilia, and/or sickle cell disease.